66 results
Page 3 of 4
8-K
pz377k7c
15 Apr 20
Other Events
9:29pm
424B5
07q wce2ykir5
2 Jan 20
Prospectus supplement for primary offering
4:50pm
S-3
EX-4.2
6415vc 68hfc2pvlg99s
20 Dec 19
Shelf registration
4:17pm
S-3
y6wp2qwpshmq hi5j
20 Dec 19
Shelf registration
4:17pm
S-3
EX-1.1
5o89uh iyzs0q2x1v4p
20 Dec 19
Shelf registration
4:17pm
8-K
EX-99.1
azowwvi
24 Sep 19
Durability of Response Determined to be 89 Percent at Six Months and 84 Percent at 12 Months
5:20pm
10-Q
162rd
9 May 19
Quarterly report
7:13am
DEF 14A
0wianj26pjeh
26 Apr 19
Definitive proxy
5:00pm
10-K
656ay1gv1po6
28 Feb 19
Annual report
1:08pm
424B5
nr7xcotw2xvv
25 Jan 19
Prospectus supplement for primary offering
8:01am
8-K
EX-1.1
i6b 4m1qdfcfn7e
25 Jan 19
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
7:30am
424B5
x0ra8am8z
22 Jan 19
Prospectus supplement for primary offering
5:12pm
8-K
EX-99.2
jheekqmmsx5hq1 mi2
22 Jan 19
UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
5:08pm